Caeruloplasmin isoforms in Wilson's disease in neonates

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 3, 1998, Pages

  Chowrimootoo, G F E ^a   Scowcroft, H ^a   Seymour, Carol A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Caeruloplasmin isoforms; Copper excretion; Wilson's disease

Indexed keywords

CERULOPLASMIN;

ARTICLE; COPPER METABOLISM; DIAGNOSTIC VALUE; HUMAN; NEWBORN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; WILSON DISEASE;

EID: 0031796265     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.3.F198     Document Type: Article

References (18)

1. Sass-Kortsak A, Bearn AG. Copper metabolism. Adv Clin Chem 1965;8:1-67.
2. th edn. New York: McGraw-Hill, 1995: Part 10 (metals): 2211-37.
3. Gutteridge JMC, Stocks J. Caeruloplasmin: physiological and pathological perspectives. Crit Rev Clin Lab Sci 1981;14:257-329.
4. Aggett PJ. Aspects of neonatal metabolism of trace metals. Acta Paediatr Suppl 1994;402:75-82.
5. Epstein O, Sherlock S. Is Wilson's disease caused by a controller gene mutation resulting in the perpetuation of the foetal mode of copper metabolism into childhood? Lancet 1981;i:303-5.
6. Srai SK, Burroughs AK, Wood B, Epstein O. The ontogeny of liver copper metabolism in the guinea pig: clues to the etiology of Wilson's disease. Hepatology 1986;6:427-32.
7. Davis W, Chowrimootoo GFE, Seymour CA. Defective biliary excretion in Wilson's disease: the role of caeruloplasmin. Eur J Clin Invest 1996;26:893-901.
8. Iyengaar V, Brewer GJ, Dick RD, Owyang C. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper binding substance in normal subjects that is absent in patients with Wilson's disease. J Lab Clin Med 1988;111:267-74.
9. Chowrimootoo GFE, Hamed HA, Seymour CA. New insights into the pathogenesis of copper toxicosis in Wilson's disease. Biochem J 1994;315:851-5.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of a bacteriophage. Nature 1970; 227:680-5.
11. Chan A, Wong F, Arumanayagam M. Serum ultratiltrable copper, total copper and caeruloplasmin concentrations in gynaecological carcinomas Ann Clin Biochem 1993;30:545-9.
12. Friedland JS, Remick DG, Shattock R, Griffin GE. Secretion of interleukin-β following phagocytosis of mycobacterium tuberculosis by human monocyte cell lines. Eur J Immunol 1992;22:1373-8.
13. Henry RJ, Chiamoris N, Jacobs SL, Seaglove M. Determination of caeruloplasmin oxidase activity in serum. Proc Soc Exp Med Biol 1960;104:620-4.
14. Dorea JG, Brito M, Araujo MOG. Concentration of copper and zinc in liver of fetuses and infants. J Am Coll Nut 1987;6:491-5.
15. Frieden E. Perspectives in copper biochemistry. Clin Physiol Biochem 1986;4:11-19.
16. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968;278:352-9.
17. Walshe JM, Yealland M. Not Wilson's disease: a review of misdiagnosed cases. Q J Med 1995;88:55-9.
18. Guthrie RE, Susi A. A simple phenylalanine method of detecting phenylketonuria in large populations of infants. Paediatr 1963;32:338-43.